Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*-Reference-Cited by-同舟云学术

Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*

Published:2009-02 Issue:2 Volume:24 Page:182-195
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:Journal of Bone and Mineral Research

Author:

Kostenuik Paul J,Nguyen Hung Q,McCabe James,Warmington Kelly S,Kurahara Carol,Sun Ning,Chen Ching,Li Luke,Cattley Russ C,Van Gwyneth,Scully Shelia,Elliott Robin,Grisanti Mario,Morony Sean,Tan Hong Lin,Asuncion Frank,Li Xiaodong,Ominsky Michael S,Stolina Marina,Dwyer Denise,Dougall William C,Hawkins Nessa,Boyle William J,Simonet William S,Sullivan John K

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Cited by 352 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Denosumab ameliorates osteoarthritis by protecting cartilage against degradation and modulating subchondral bone remodeling;Regenerative Therapy;2024-12

2. Multi-omics profiling of retinal pigment epithelium reveals enhancer-driven activation of RANK-NFATc1 signaling in traumatic proliferative vitreoretinopathy;Nature Communications;2024-08-25

3. Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells;Cell Death Discovery;2024-08-24

4. Osteoporosis treatment: current drugs and future developments;Frontiers in Pharmacology;2024-08-12

5. RAC1 inhibition ameliorates IBSP-induced bone metastasis in lung adenocarcinoma;Cell Reports;2024-08